At the news
? NEUTRALIMPACT 3/10 PRESS-RELEASE filed Mar 24, 2026 at 16:05 ET
PDS Biotechnology announced it will report its Q4 and full-year 2025 financial results and provide a clinical update on March 30, 2026. The press release contains no actual financial or operational data, only a notification of an upcoming earnings call.
- PDS Biotech will report financial results for Q4 and full-year 2025 on March 30, 2026.
- The announcement includes a clinical programs and corporate update.
- No financial figures, guidance, or operational results were disclosed in this release.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access